231 related articles for article (PubMed ID: 15684491)
41. Hydroxyethyl cyclosporin A induces and decreases P4503A and P-glycoprotein levels in rat liver.
Vickers AE; Alegret M; Meyer E; Smiley S; Guertler J
Xenobiotica; 1996 Jan; 26(1):27-39. PubMed ID: 8851819
[TBL] [Abstract][Full Text] [Related]
42. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.
Dresser GK; Schwarz UI; Wilkinson GR; Kim RB
Clin Pharmacol Ther; 2003 Jan; 73(1):41-50. PubMed ID: 12545142
[TBL] [Abstract][Full Text] [Related]
43. A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers.
Min DI; Ku YM; Vichiendilokkul A; Fleckenstein LL
Pharmacotherapy; 1999 Jun; 19(6):753-9. PubMed ID: 10391422
[TBL] [Abstract][Full Text] [Related]
44. Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies.
Venkatakrishnan K; Schmider J; Harmatz JS; Ehrenberg BL; von Moltke LL; Graf JA; Mertzanis P; Corbett KE; Rodriguez MC; Shader RI; Greenblatt DJ
J Clin Pharmacol; 2001 Oct; 41(10):1043-54. PubMed ID: 11583471
[TBL] [Abstract][Full Text] [Related]
45. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.
Zhang Y; Benet LZ
Clin Pharmacokinet; 2001; 40(3):159-68. PubMed ID: 11327196
[TBL] [Abstract][Full Text] [Related]
46. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
Kharasch ED; Walker A; Hoffer C; Sheffels P
Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
[TBL] [Abstract][Full Text] [Related]
47. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.
Yamano K; Yamamoto K; Katashima M; Kotaki H; Takedomi S; Matsuo H; Ohtani H; Sawada Y; Iga T
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):443-52. PubMed ID: 11259329
[TBL] [Abstract][Full Text] [Related]
48. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Masica AL; Mayo G; Wilkinson GR
Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
[TBL] [Abstract][Full Text] [Related]
49. Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes.
Guns ES; Bullock PL; Reimer ML; Dixon R; Bally M; Mayer LD
Eur J Drug Metab Pharmacokinet; 2001; 26(4):273-82. PubMed ID: 11808870
[TBL] [Abstract][Full Text] [Related]
50. Metabolism of cyclosporine after orthotopic liver transplantation.
Fabre JM; Pedrosa R; Bonardet A; Pichard L; Descomps B; Domergue J; Baumel H; Maurel P
Biochem Pharmacol; 1993 Oct; 46(7):1151-7. PubMed ID: 8216365
[TBL] [Abstract][Full Text] [Related]
51. Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies.
Sigafoos JF; Bowers GD; Castellino S; Culp AG; Wagner DS; Reese MJ; Humphreys JE; Hussey EK; O'Connor Semmes RL; Kapur A; Tao W; Dobbins RL; Polli JW
Drug Metab Dispos; 2012 Nov; 40(11):2090-101. PubMed ID: 22851617
[TBL] [Abstract][Full Text] [Related]
52. Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine.
Ni L; Yu X; Yu Q; Chen X; Jia L
Drug Metab Lett; 2008 Aug; 2(3):163-8. PubMed ID: 19356088
[TBL] [Abstract][Full Text] [Related]
53. Metabolism and effect of para-toluene-sulfonamide on rat liver microsomal cytochrome P450 from in vivo and in vitro studies.
Zhou JQ; Tang ZQ; Zhang JN; Tang JC
Acta Pharmacol Sin; 2006 May; 27(5):635-40. PubMed ID: 16626521
[TBL] [Abstract][Full Text] [Related]
54. Alterations in P-glycoprotein expression in mouse tissues by doxorubicin: implications for pharmacokinetics in multiple dosing regimens.
Gustafson DL; Long ME
Chem Biol Interact; 2001 Oct; 138(1):43-57. PubMed ID: 11640914
[TBL] [Abstract][Full Text] [Related]
55. Effect of indinavir on the intestinal exsorption of amprenavir, saquinavir and nelfinavir after intravenous administration in rats.
Gao W; Kageyama M; Inoue Y; Tadano J; Fukumoto K; Fukushima K; Yamasaki D; Nishimura A; Yoshikawa Y; Shibata N; Takada K
Biol Pharm Bull; 2003 Feb; 26(2):199-204. PubMed ID: 12576680
[TBL] [Abstract][Full Text] [Related]
56. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
[TBL] [Abstract][Full Text] [Related]
57. Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells.
Nguyen NS; Cottet-Maire F; Buetler TM; Lo Russo A; Krauskopf AS; Armstrong JM; Vickers AE; Macé K; Rüegg UT
Free Radic Biol Med; 1999 Dec; 27(11-12):1267-75. PubMed ID: 10641720
[TBL] [Abstract][Full Text] [Related]
58. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986
[TBL] [Abstract][Full Text] [Related]
59. Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.
von Moltke LL; Durol AL; Duan SX; Greenblatt DJ
Eur J Clin Pharmacol; 2000 Jun; 56(3):259-61. PubMed ID: 10952482
[TBL] [Abstract][Full Text] [Related]
60. Interaction of Rhei Rhizoma extract with cytochrome P450 3A and efflux transporters in rats.
Yokooji T; Kida M; Mori M; Akashi H; Mori N; Yoshihara S; Murakami T
Pharmazie; 2010 May; 65(5):367-74. PubMed ID: 20503931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
